Sun Pharma to acquire Organon in $11.75 billion deal
Summary
The deal, valued at $11.75 billion including debt, would push Sun Pharma into the top 25 global pharmaceutical companies
Description
The deal, valued at $11.75 billion including debt, would push Sun Pharma into the top 25 global pharmaceutical companies
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source